Neuronetics, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US64131A1051
USD
1.42
-2.3 (-61.83%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Delcath Systems, Inc.
Akili, Inc.
Neuronetics, Inc.
Eargo, Inc.
ReWalk Robotics Ltd.
Sonendo, Inc.
IRIDEX Corp.
Sensus Healthcare, Inc.
DermTech, Inc.
Daxor Corp.
Meihua International Medical Technologies Co., Ltd.

Why is Neuronetics, Inc. ?

1
Poor long term growth as Operating profit has grown by an annual rate -6.47% of over the last 5 years
2
The company has declared Negative results for the last 4 consecutive quarters
  • OPERATING CASH FLOW(Y) Lowest at USD -34.51 MM
  • NET PROFIT(HY) At USD -22.8 MM has Grown at -28.75%
  • ROCE(HY) Lowest at -207.57%
3
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 7.52%, its profits have fallen by -58.3%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Neuronetics, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Neuronetics, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Neuronetics, Inc.
-100.0%
-0.29
101.30%
S&P 500
13.99%
0.81
19.85%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
15.28%
EBIT Growth (5y)
-6.47%
EBIT to Interest (avg)
-6.07
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.10
Sales to Capital Employed (avg)
0.99
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
52.24%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
6.91
EV to EBIT
-7.43
EV to EBITDA
-7.93
EV to Capital Employed
3.82
EV to Sales
3.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-51.42%
ROE (Latest)
-122.96%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

19What is working for the Company
NET PROFIT(HY)

Higher at USD -22.8 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 9.29 times

NET SALES(Q)

Highest at USD 38.11 MM

OPERATING PROFIT(Q)

Highest at USD -7.16 MM

OPERATING PROFIT MARGIN(Q)

Highest at -18.78 %

EPS(Q)

Highest at USD -0.15

-14What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at USD -34.51 MM

NET PROFIT(HY)

At USD -22.8 MM has Grown at -28.75%

ROCE(HY)

Lowest at -207.57%

DEBT-EQUITY RATIO (HY)

Highest at 232.11 %

RAW MATERIAL COST(Y)

Grown by 37.94% (YoY

CASH AND EQV(HY)

Lowest at USD 39.07 MM

Here's what is working for Neuronetics, Inc.

Net Sales
At USD 38.11 MM has Grown at 131.66%
Year on Year (YoY)
MOJO Watch
Near term sales trend is extremely positive

Net Sales (USD MM)

Net Sales
Highest at USD 38.11 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Net Profit
Higher at USD -22.8 MM
than preceding 12 month period ended Jun 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Inventory Turnover Ratio
Highest at 9.29 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Operating Profit
Highest at USD -7.16 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at -18.78 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

EPS
Highest at USD -0.15
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Here's what is not working for Neuronetics, Inc.

Net Profit
At USD -22.8 MM has Grown at -28.75%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

Debt-Equity Ratio
Highest at 232.11 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Cash Flow
Lowest at USD -34.51 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Cash and Eqv
Lowest at USD 39.07 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost
Grown by 37.94% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales